FR | NL
Home | Over Vax Info | Links | Contacteer ons

Verklaring van belangenconflict

De leden van de groep hebben een verklaring van belangenconflict opgesteld.
Deze verklaringen worden hier gepubliceerd.

  • Hugues Bogaerts, founder of HB Consult sprl in 2011, is an independent consultant in Vaccinology and immunology to the biopharma industry. Formerly he was an employee of GSK Vaccines.
  • Tinne Boiy acts as an investigator for trials conducted on behalf of the department of Pediatrics at the University Hospital Antwerp. The department receives fees for clinical research trials paid directly to a research fund. She has not received any personal remuneration for this work.
  • Marc De Ridder, clinical immunologist, founder of Vaxconsult in 2016, lecturer at ULB in Vaccinology, and independent consultant in Vaccinology and immunology to the biopharma industry. Formerly he was an employee of GSK Vaccines.
  • Julie Frère acts as an investigator for trials conducted on behalf of the department of Pediatrics at the Hospital of La Citadelle in Liège. The department receives fees for clinical research trials paid directly to a research/educational fund. She also received speaker fees, paid personally or to the educational fund or the research fund.
  • Philippe Lepage
  • Geert Leroux-Roels acts as the head and the principal investigator of the Center for Vaccinology of the Ghent University and Ghent University Hospital. Both institutions are compensated for the clinical and analytical work conducted in the context of the commissioned clinical trials. Geert Leroux-Roels further acts as an independent consultant for several vaccine companies and is personally remunerated for these services.
  • Inge Matthijs
  • Marc Raes acts as the president of the Working Group of the Flemish Society of Pediatrics: “Vaccination and Infections”. He was involved in the organisation of many symposia about vaccines with the support of different vaccine companies, but without any personal remuneration. He received speakers fees for presentations on vaccines and was personnaly remunerated as an independent consultant for vaccine companies. As a private pediatrician, he conducted clinical vaccination studies for different companies in collaboration with his local colleagues. Paiments were made directly to the pediatric association.
  • Petra Schelstraete acts as an investigator for trials conducted on behalf of the Pediatric Pulmonology and Infectious Diseases Department of the Ghent University Hospital. She obtained research grants from vaccine companies in the past years paid directly to the research fund of the Pediatric Pulmonology Department . She also received speaker fees, paid personally or to the research fund.
  • Béatrice Swennen
  • Pierre Van Damme acts as chief and principal investigator for vaccine trials conducted on behalf of the University of Antwerp, for which the University obtains research grants from vaccine manufacturers; speakers fees for presentations on vaccines are paid directly to an educational fund held by the University of Antwerp. PVD receives no personal remuneration for this work
  • Koen Van Herck acts as an investigator for the department of Public Health of Ghent University and for the Vaccine and Infectious Disease Institute of the University of Antwerp. Both institutions are compensated through research grants for the work conducted in the context of vaccine trials and epidemiologic studies. Consultancy or speakers’ fees are paid directly to an educational fund held by the abovementioned institutions. Koen Van Herck receives no personal remuneration for this work.
  • Françoise Vermeulen acts as an investigator for trials conducted on behalf of the Department of Pediatrics and the Neonatal Intensive Care Unit of The Hôpital Erasme and the Laboratory of Vaccinology and Mucosal Immunity of the Université Libre de Bruxelles (ULB). She obtained in the past different research grants directly paid to the research fund held by the institutions Hôpital Erasme and ULB. She receives no personal remuneration for this work.

Abonneer u op de nieuwsbrief